Inventor · disambiguated record
Darren Mcmurtrie
Also filed as: MCMURTRIE DARREN · MCMURTRIE DARREN J · MCMURTRIE DARREN JOHN
51 granted patents·5 pending applications·337 citations·filing 2005–2025
98Inventor score
Files withRIGEL PHARMACEUTICALS INC21CHEMOCENTRYX INC17ALLEGRETTI PAUL7THERAVANCE INC4BHAMIDIPATI SOMASEKHAR2
Top patents by PatentIndex Score
56 records- 0198US11426364B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Aug 30, 2022·10 cites·6 claims
- 0298US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0397US11485708B2Compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·9 cites·21 claims
- 0497US11266643B2Triaryl compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Mar 8, 2022·13 cites·32 claims
- 0597US10639284B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2017·Granted May 5, 2020·17 cites·30 claims
- 0697US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 0796US11713307B2Heteroaryl-biphenyl amides for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Aug 1, 2023·8 cites·28 claims
- 0896US11691985B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2021·Granted Jul 4, 2023·4 cites·20 claims
- 0996US11059834B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·10 cites·18 claims
- 1096US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 1195US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 1295US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 1395US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 1493US10392405B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2018·Granted Aug 27, 2019·13 cites·46 claims
- 1592US9067925B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·11 cites·10 claims
- 1692US8158659B2Dual-acting imidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2010·Granted Apr 17, 2012·11 cites·32 claims
- 1790US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 1889US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 1989US8343954B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·8 cites·7 claims
- 2089US7642339B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2005·Granted Jan 5, 2010·15 cites·9 claims
- 2189US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2288US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 2388US9611260B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·14 claims
- 2486US8344013B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 1, 2013·4 cites·7 claims
- 2586US8268851B2Compositions and methods for inhibition of the JAK pathwayBHAMIDIPATI SOMASEKHAR·Filed 2009·Granted Sep 18, 2012·8 cites·14 claims
- 2686US8236846B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Aug 7, 2012·5 cites·24 claims
- 2784US10479783B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Nov 19, 2019·2 cites·6 claims
- 2884US8569351B2Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2012·Granted Oct 29, 2013·3 cites·3 claims
- 2983US10941140B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·2 cites·26 claims
- 3083US9920041B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Mar 20, 2018·2 cites·12 claims
- 3183US8895755B2Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2013·Granted Nov 25, 2014·3 cites·1 claims
- 3283US8349875B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 8, 2013·3 cites·24 claims
- 3382US11993594B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted May 28, 2024·0 cites·17 claims
- 3481US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 3580US12371433B2Heteroaryl-biphenyl amines for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2023·Granted Jul 29, 2025·0 cites·13 claims
- 3680US2022289776A1Pyrazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3780US2022024907A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3879US2025346598A1Heteroaryl-biphenyl amines for the treatment of pd-l1 diseasesCHEMOCENTRYX INC·Filed 2025·Application pending·0 cites
- 3978US10370367B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·21 claims
- 4078US8420659B2Compositions and methods for inhibition of the JAK pathwayBHAMIDIPATI SOMASEKHAR·Filed 2012·Granted Apr 16, 2013·3 cites·13 claims
- 4177US11174251B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Nov 16, 2021·0 cites·17 claims
- 4276US9150514B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2014·Granted Oct 6, 2015·1 cites·26 claims
- 4375USRE47396ECompositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted May 21, 2019·1 cites·10 claims
- 4474US12497383B2Heteroaryl-biphenyl amides for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2023·Granted Dec 16, 2025·0 cites·20 claims
- 4574US11793771B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2022·Granted Oct 24, 2023·0 cites·19 claims
- 4670US11370808B2Pyrazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 28, 2022·0 cites·17 claims
- 4769US8637676B2Dual-acting benzoimidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2008·Granted Jan 28, 2014·0 cites·33 claims
- 4868US11866429B2Heteroaryl-biphenyl amines for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Jan 9, 2024·0 cites·26 claims
- 4966US8278299B2Pyrimidinediamine kinase inhibitorsSINGH RAJINDER·Filed 2009·Granted Oct 2, 2012·0 cites·37 claims
- 5062US9040527B2Pyrimidinediamine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2013·Granted May 26, 2015·0 cites·11 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →